Clinical Drug Experience Knowledgebase

Alkalosis (Phase 3)

Aneurysm (Phase 4)

Aortic Aneurysm (Phase 4)

Aortic Aneurysm, Abdominal (Phase 4)

Arachnodactyly (Phase 3)

Bone Diseases, Metabolic (Phase 4)

Borderline Personality Disorder (Phase 2)

Bronchiectasis (Phase 3)

Cardiomyopathies (Phase 4)

Communicable Diseases (Phase 2)

Coronary Artery Disease (Phase 4)

Coronary Disease (Phase 4)

Crohn Disease (Phase 2)

Cystic Fibrosis (Phase 4)

Delirium (Phase 3)

Depression (Phase 4)

Depressive Disorder (Phase 4)

Depressive Disorder, Major (Phase 4)

Depressive Disorder, Treatment-Resistant (Phase 1)

Disease (Phase 4)

Fibrosis (Phase 4)

Glioblastoma (Phase 1)

Heart Failure (Phase 4)

Infections (Phase 2)

Kidney Failure, Chronic (Phase 3)

Leukemia (Phase 1)

Leukemia, Myeloid (Phase 1)

Leukemia, Myeloid, Acute (Phase 1)

Lung Diseases (Phase 2)

Lung Diseases, Obstructive (Phase 3)

Lymphoma (Phase 2)

Lymphoma, B-Cell (Phase 2)

Lymphoma, Large B-Cell, Diffuse (Phase 2)

Marfan Syndrome (Phase 3)

Multiple Myeloma (Phase 1)

Myelodysplastic Syndromes (Phase 1)

Myocardial Ischemia (Phase 4)

Neoplasms, Plasma Cell (Phase 1)

Osteoporosis (Phase 4)

Pain, Postoperative (Phase 4)

Parkinson Disease (Phase 2)

Personality Disorders (Phase 2)

Preleukemia (Phase 1)

Psoriasis (Phase 1)

Psychomotor Agitation (Phase 2)

Psychotic Disorders (Phase 4)

Renal Insufficiency (Phase 3)

Respiratory Tract Infections (Phase 2)

Schizophrenia (Phase 4)

Syndrome (Phase 3)

Waldenstrom Macroglobulinemia (Phase 2)